Clinical Trial Detail

NCT ID NCT01351415
Title A Study of Avastin (Bevacizumab) in Combination With Standard of Care Treatment in Patients With Lung Cancer
Recruitment Completed
Gender both
Phase Phase III
Variant Requirements No
Sponsors Hoffmann-La Roche
Indications

lung non-small cell carcinoma

Therapies

Bevacizumab

Age Groups: adult

No variant requirements are available.